Evaluation of Physical Characteristic in Ciprofloxacin Tablet Dosage Form and Quantitative Analysis by UV- Spectrophotometry and HPLC

        
Nigar A. Najim, Renas R. Jalal, Nigar M. Qadr & Sakar B. Sabeer

School of Pharmacy, Faculty of Medical Sciences, University of Sulaimani

DOI: https://doi.org/10.17656/jzs.10545

Abstract

Ciprofloxacin is used as an active ingredient in different dosage forms, including tablet, which is used for treatment of various infectious diseases. Quantitative determination was performed by UV/Visible spectrophotometer and high performance liquid chromatography. Evaluation of the physicochemical property of Ciprofloxacin was performed by various methods: weight uniformity test, friability, hardness, thickness, diameter, disintegration, dissolution test loss on drying and Karl Fischer titration. The results have shown that the percentages of the assay witch determined by UV/Visible spectrophotometry and HPLC are complying with United State Pharmacopeia. The results for weight variations, diameter, thickness, hardness, friability, water content, disintegration and dissolution are within the normal range. In addition, there is no significant difference between core and coated tablets. Ciproneer tablets (Ciprofloxacin, Pioneer, Iraq) of this batch can be marketed and prescribed for the patient because it is safe and effective.

Key Words: Ciprofloxacin, Quantitative, Physical Characteristic,  UV-Spectrophotometry, HPLC



References

[1] A. Kasture , S. Wadodkar, K. Mahadic and H. More,“Pharmaceutical Chemistry -I”: 25th Edition. Abhyudaya Pragati, N. India, pp. 1-2, (2008).

[2] K. A. kishore and P. Amareshwar, “Quality Evaluation and Comparative Study on Tablet Formulations 
of Different pharmaceutical Companies”, J. Curr. Chem. Pharm. Sci., Vol.2, No.1, pp 24-31, (2012).

[3] A. Loyd, P. Nicholas and A. Howard, "Ansel's Pharmaceutical Dosage Forms and Drug Delivery 
SystemsSolid Dosage Forms and Solid Modified-Release Drug Delivery Systems": 9th Edition. Lippincott Williams and Wilkins, Philadelphia, pp. 232, (2011).

[4] K. Harbir “Processing Technologies for Pharmaceutical tablets: A review”, IRJP, Vol,3, No,7, pp 20-23, 
(2012).

[5] M.C. Gohel and P.D. Jogani, “A Review of Co-Processed Directly Compressible Excipients”, J.Pharm. 
Sci. Can., Vol,8, No,1, pp 76-93, (2005).

[6] M. Clark, "Lippincott’s Illustrated Reviews: Pharmacology":5th Edition, R. Harvey Clark, M. Finkel, R 
and Rey, J. Whalen K. Philadelphia, pp 409-427, (2012).

[7] A. A. Sani, C. C. Mmuo, R. O. Abdulraheem, S. S. Abdulkareem, E. T. Alemika, M. A. Sani and M. 
Ilyas, “High Performance Liquid Chromatography (HPLC) Method Development and Validation Indicating Assay for Ciprofloxacin Hydrochloride”, J. Appl. Pharm.Sci.Vol.1, No.8, pp 239-243, (2011).

[8]T. H. Fereja, M. F. Seifu and T. Y. Mola, “UV-Visible Spectrophotometric Method Development and 
Quantification of Ciprofloxaciline in Tablets Dosage Forms”, AACIT, Vol. 2, No.1, pp 1-8, (2015).

[9] F. Varanda, M. J. Pratas, A. I. Cacüo, R. Dohrn, F. Makrydaki, E. Voutsas, D. Tassios and I. M. Marrucho, “Solubility of Antibiotics in Different Solvents, 1.Hydrochloride Forms of Tetracycline, Moxifloxacin and Ciprofloxacin”, Ind. Eng. Chem. Res., Vol.45, No.18, pp 6368-6374 ,(2006).

[10] F. William, L. Thomas and W. Daived, “Foye's Principles of Medicinal Chemistry”: 7th Edition. 
Williams and Wilkins, Philadelphia, pp. 32, (2012).

[11] A. I. CaÇo, F.Varanda, M. J. Pratas de melo, A. M. A. Dias and I. M. Marrucho, “Solubility of 
Antibiotics in Different Solvents. Part II:Non-Hydrochloride Forms of Tetracycline and Ciprofloxacin”, Ind. Eng.Chem. Res.,Vol. 47, No.21, pp 8083-8089, (2008).

[12] S. Harder, U. Fuhr, D. Beermann and A. Staib, “Ciprofloxacin Absorption in Different Regions of the 
Human Gastrointestinal Tract Investigations with the hf-Capsule”, Br. J. Clin. Pharmacol., Vol.30, No.1, pp 35-39, (1990).

[13] H. Hopkala and D. Kawalczuk, “Application of Derivative of Uv-Spectrophotometry for the 
Determination of Ciprofloxacin, Norfloxacin, and Ofloxacin in Tablets”: Acta Pol. Pharm., Vol.57, No.1, pp 3-31, (2000).

[14] N. C. Ngwuluka , K. Lawal, P. O. Olorunfemi and N. A. Ochekpe, “Post-market in Vitro 
Bioequivalence Study of Six Brands of Ciprofloxacin Tablets/Caplets in Jos, Nigeria”, Sci. Res. Essays., Vol.4, No.4, pp 298-305, (2009).

[15] S. Vinay, R. S. Bhat, V. Balamuralidhara and T. M. P. Kumar, “Comparative Study of In-process and 
Finished Products Quality Control Tests of IP, BP & USP for Tablets”, IJPTP. Vol.2, No.4, pp 176-183, (2011).

[16] S. Nandipati, K. R. Vanka and S. Uba, “The Separation and Quantitative Determination of 
Ciprofloxacin in a Pharmaceutical Formulation by Ultra Performance Liquid Chromatography”, Int. J. Pharm. Pharm.Sci., Vol.5, No.3, pp 312-317, (2013).

[17] S. O. Sarr, S. M. Ndiaye, D. Fall, A. Diedhiou, A. Diop, B. Ndiaye and Y. M. Diop, “Development and 
Validation of a Simple and Economical Spectrofluorimetric Method for Estimation of Ciprofloxacin in Pharmaceutical Dosage Forms”, Int. J. Anal. Bioanal. Chem. Vol.3, No.3, pp 72-77, (2013).

[18] L. Levi, G. C. Walker and L. I. Pugsley, "Quality Control of Pharmaceuticals", Can. Med. Assoc. J., 
Vol.91, No.15, pp 781-785, (1964).

[19] G. Kahsay and A.G. Egziabher, “Quality Assessment of the Commonly Prescribed Antimicrobial Drug, 
Ciprofloxacin Tablets, Marketed in Tigray, Ethiopia”, MEJS, Vol.2, No.1, pp 93-107, (2010).

[20] L. D. S. Yadav, “Organic Spectroscopy”: Kluwer B. New Delhi, India, pp. 29, (2005).

[21] E. C. L. Cazedey and H. R. N. Salgado, "Spectrophotometric Determination of Ciprofloxacin 
Hydrochloride in Ophthalmic Solution", Adv. Anal. Chem., Vol.2,No.6, pp 74-79, (2012).

[22] B. H. Kim, N. Hee Choi and J. Hoa Ok, “Comparison of Reversed-Phase Liquid Chromatographic 
Methods for the Separation of New Quinolones”, J. Chromatogra. Sci., Vol.40, No.7, pp 305-380. (2002).

[23] R. Nogueira, S. M. Queiroz, G. E. B. Silva,W. F.C. Rocha, G. F. Sarmanho, R. R. R Almeidaa and G. 
F. Moreira, “Determination of Volatiles in Pharmaceutical Certified Reference Materials”, J. Braz. Chem. Soc., Vol.23, No.9, pp 1636- 1646, (2012).

[24] J. V. Kenkel, "Analytical Chemistry for Technician": 3rd Edition. United State America, pp. 34-75, 
(2003).

[25] C. R. Behl, H. Car, S. B. Patel, D. B. Mehta, D. Piemontese and A. W. Malick, “Topical Drug 
Bioavailability and Bioequivalence and Penetrations: In-Vitro and In-Vivo Skin Uptake and Permeation Studies: Critical Considerations and Factors Which Affect Them”: Shah V, Maibach H. New York, pp. 229, (1993).

[26] United State Pharmacopeia. “ Monograph Ciprofloxacin Tablets”, US Pharmacopria convention. Inc 
Rockville M. USP37/NF32. Vol.35, pp 2355, (2015).

[27] G. Harish, C. Bhargavi, A. Riyajune, M. Yasmeen, S. Mohammed, C. M. Krishna, S. Jilani and A. V. 
Nirajana,“Effect of Different Disintegrates on Ciprofloxacin Conventional Tablets”, IJRPB, Vol.1, No.3, pp 284-287, (2013).

[28] N. Nasrin, M. Asaduzzaman, R. Mowla, F. Rizwan and A. Alam, “A Comparative Study of Physical Parameters of Selected Ketorolac Tromethamine Tablets Available in the Pharma Market of Bangladesh”, JAPS, Vol.1, No.8, pp 101-103, (2011).

[29] A. D. Salman, M. Ghadiri, and M. J. Hounslow, “Particle Breakage: Handbook of Powder Technology- 
12”: Elsevier. London, pp.960, (2007).

[30] B. N. V. Hari, V. Abbirami, P. Sainithya, A.Shobana and D. R. Devi, “In-Vitro Bioequivalence Study 
and Effect of Food Beverages on Various Brands of Aceclofenac Available in Indian Market”, JCPS, Vol.7, No.1, pp 1-7, (2014).

[31] L. L. Augsburger, and S. W. Hoag “Pharmaceutical Dosage Forms – Tablets: Unit Operation and 
Mechanical Property-1”: 3rd Edition. CRC, Taylore and Francis, New York, pp. 220, (2008).

[32] S. Usman, A. Alam, R.Suleiman, K. Awad and I. Abudeek, “Evaluation of Dissolution Testing for Ciprofloxacin (500mg) Tablets: Post Market Surveillance of Different Brands Availability in Ras Alkhaimah (UAE)”, I. J. B., Vol.5, No.1, pp 65-72, (2014).

[33] S. Agrwal and R. Khana, “Physical Pharmacy: Diffusion and Dissolution”, 2nd Edition. Sharma B. 
India, pp. 239, (2006).

[34] E. C. L. Cazedey, R. Bonfilio, M. B. Araújo and H. R. N. Salgado, “A First-Derivative 
Spectrophotometric Method for the Determination of Ciprofloxacin Hydrochloride in Ophthalmic Solution”, JPC, Vol.2, No.6, pp 116-122, (2012).

[35] J. Mu’az, K. L. Gazali, U. G. Sadiq and M. G. Tom, “Comparative in Vitro Evaluation of the 
Pharmaceutical and Chemical Equivalence of Multi-Source Generic Ciprofloxacin Hydrochloride Tablets Around Maiduguri Metropolitan Area”, Nig. J. Pharm. Sci., Vol.8, No.2, pp 102- 106, (2009).

[36] J. C. Callahan, G. W. Cleary, M. Elefant, G. Kaplan, T. Kensler and R. A. Nash, “Equilibrium Moisture 
Content of Pharmaceutical Excipients”, Drug Dev. Ind. Pharm., Vol.8, No.3, pp 355-369, (1982).

[37] P. Thomas, “Physicians' Desk Reference 2004: Supplemen”. 58th Edition. Thmson, England, pp.78, 
(2004).

[38] British Pharmacopeia. “Monographs Medicinal and Pharmaceutical Substances: Ciprofloxacin 
Hydrochloride”, British Pharmacopeia. Volume (I and II), (2009).

[39] T. H. Fereja and S. B. Tufa, “In Vitro Quality Assessment and Bioequivalence Studies on Four Brands 
of Ciprofloxacin Tablets, Marketed in Ambo, Ethiopia”, Int. J. Pharm. Sci. Vol.5, No.2, pp 1007- 1012,(2015).